EuBiologics Co., Ltd. 206650.KQ Stock
EuBiologics Co., Ltd. Price Chart
EuBiologics Co., Ltd. 206650.KQ Financial and Trading Overview
| EuBiologics Co., Ltd. stock price | 13480 KRW |
| Previous Close | 7420 KRW |
| Open | 7400 KRW |
| Bid | 7420 KRW x 0 |
| Ask | 7430 KRW x 0 |
| Day's Range | 7380 - 7600 KRW |
| 52 Week Range | 6950 - 18500 KRW |
| Volume | 190.94K KRW |
| Avg. Volume | 385.9K KRW |
| Market Cap | 189.92B KRW |
| Beta (5Y Monthly) | 1.641202 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
206650.KQ Valuation Measures
| Enterprise Value | 304.15B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.7627752 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.026 |
| Enterprise Value/EBITDA | 69.569 |
Trading Information
EuBiologics Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.641202 |
| 52-Week Change | -51.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18500 KRW |
| 52 Week Low | 6950 KRW |
| 50-Day Moving Average | 7622.4 KRW |
| 200-Day Moving Average | 9569.85 KRW |
206650.KQ Share Statistics
| Avg. Volume (3 month) | 385.9K KRW |
| Avg. Daily Volume (10-Days) | 425.45K KRW |
| Shares Outstanding | 25.29M |
| Float | 26.47M |
| Short Ratio | N/A |
| % Held by Insiders | 22.23% |
| % Held by Institutions | 5.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 4.00% |
| Operating Margin (ttm) | -6.23% |
| Gross Margin | 44.01% |
| EBITDA Margin | 8.66% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 50.47B KRW |
| Revenue Per Share (ttm) | 1388.03 KRW |
| Quarterly Revenue Growth (yoy) | 17.89% |
| Gross Profit (ttm) | 15.22B KRW |
| EBITDA | 4.37B KRW |
| Net Income Avi to Common (ttm) | 2.02B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | -87.70% |
Balance Sheet
| Total Cash (mrq) | 14.87B KRW |
| Total Cash Per Share (mrq) | 408.08 KRW |
| Total Debt (mrq) | 15.7B KRW |
| Total Debt/Equity (mrq) | 12.76 KRW |
| Current Ratio (mrq) | 1.937 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.27B KRW |
| Levered Free Cash Flow (ttm) | N/A |
Profile of EuBiologics Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Bomnal-A-Chim B/D |
| ZIP | N/A |
| Phone | 82 2 572 6675 |
| Website | https://www.eubiologics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
EuBiologics Co., Ltd., a biopharmaceutical company, develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine. The company also provides customized services for mammalian cell and microbial cell derived biopharmaceuticals in accordance with the clients' project stages, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. It specializes in manufacturing a range of mammalian cell and microbial cell derived biopharmaceuticals, including recombinant biological products and antibody therapeutics. In addition, the company offers process, formulation, and analytical method development, as well as licensing consulting services; and contract testing services that include lot release, stability, raw material, and method validation testing services. The company was founded in 2010 and is based in Seoul, South Korea.
Q&A For EuBiologics Co., Ltd. Stock
What is a current 206650.KQ stock price?
EuBiologics Co., Ltd. 206650.KQ stock price today per share is 13480 KRW.
How to purchase EuBiologics Co., Ltd. stock?
You can buy 206650.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EuBiologics Co., Ltd.?
The stock symbol or ticker of EuBiologics Co., Ltd. is 206650.KQ.
How many shares does EuBiologics Co., Ltd. have in circulation?
The max supply of EuBiologics Co., Ltd. shares is 25.29M.
What is EuBiologics Co., Ltd. Price to Earnings Ratio (PE Ratio)?
EuBiologics Co., Ltd. PE Ratio is now.
What was EuBiologics Co., Ltd. earnings per share over the trailing 12 months (TTM)?
EuBiologics Co., Ltd. EPS is 0 KRW over the trailing 12 months.
EuBiologics Co., Ltd. 206650.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}